23 related articles for article (PubMed ID: 8066072)
1. Molecular characteristics of malignant ovarian germ cell tumors and comparison with testicular counterparts: implications for pathogenesis.
Kraggerud SM; Hoei-Hansen CE; Alagaratnam S; Skotheim RI; Abeler VM; Rajpert-De Meyts E; Lothe RA
Endocr Rev; 2013 Jun; 34(3):339-76. PubMed ID: 23575763
[TBL] [Abstract][Full Text] [Related]
2. p53 antibodies in the serum of patients with prostate cancer.
Kubota Y; Onmura Y; Ohji H; Kunii T; Shibasaki T; Nakada T; Tomita Y
Int Urol Nephrol; 2008; 40(1):79-84. PubMed ID: 17619164
[TBL] [Abstract][Full Text] [Related]
3. The MDM2 gene amplification database.
Momand J; Jung D; Wilczynski S; Niland J
Nucleic Acids Res; 1998 Aug; 26(15):3453-9. PubMed ID: 9671804
[TBL] [Abstract][Full Text] [Related]
4. p53-Dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells.
Zamble DB; Jacks T; Lippard SJ
Proc Natl Acad Sci U S A; 1998 May; 95(11):6163-8. PubMed ID: 9600935
[TBL] [Abstract][Full Text] [Related]
5. Germ cell tumors of the testis overexpress wild-type p53.
Guillou L; Estreicher A; Chaubert P; Hurlimann J; Kurt AM; Metthez G; Iggo R; Gray AC; Jichlinski P; Leisinger HJ; Benhattar J
Am J Pathol; 1996 Oct; 149(4):1221-8. PubMed ID: 8863671
[TBL] [Abstract][Full Text] [Related]
6. Lack of mutation in tumour-suppressor gene p53 in gestational trophoblastic tumours.
Shi YF; Xie X; Zhao CL; Ye DF; Lu SM; Hor JJ; Pao CC
Br J Cancer; 1996 May; 73(10):1216-9. PubMed ID: 8630281
[TBL] [Abstract][Full Text] [Related]
7. Molecular biology of testicular germ cell tumors: current status.
Schmidt B; Ackermann R; Strohmeyer T
J Mol Med (Berl); 1995 Jul; 73(7):355-67. PubMed ID: 8520968
[No Abstract] [Full Text] [Related]
8. Molecular mechanisms of testicular carcinogenesis.
Rukstalis DB
World J Urol; 1996; 14(5):347-52. PubMed ID: 8912475
[TBL] [Abstract][Full Text] [Related]
9. Mutations of the p53 gene are not detectable in human testicular tumors.
Fleischhacker M; Strohmeyer T; Imai Y; Slamon DJ; Koeffler HP
Mod Pathol; 1994 May; 7(4):435-9. PubMed ID: 8066072
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
[TBL] [Abstract][Full Text] [Related]
11. Mutations of the p53 gene do not occur in testis cancer.
Peng HQ; Hogg D; Malkin D; Bailey D; Gallie BL; Bulbul M; Jewett M; Buchanan J; Goss PE
Cancer Res; 1993 Aug; 53(15):3574-8. PubMed ID: 8339263
[TBL] [Abstract][Full Text] [Related]
12. Role of p53 mutations in endocrine tumorigenesis: mutation detection by polymerase chain reaction-single strand conformation polymorphism.
Yoshimoto K; Iwahana H; Fukuda A; Sano T; Saito S; Itakura M
Cancer Res; 1992 Sep; 52(18):5061-4. PubMed ID: 1516062
[TBL] [Abstract][Full Text] [Related]
13. Use of the single strand conformation polymorphism technique and PCR to detect p53 gene mutations in small cell lung cancer.
Hensel CH; Xiang RH; Sakaguchi AY; Naylor SL
Oncogene; 1991 Jun; 6(6):1067-71. PubMed ID: 1648702
[TBL] [Abstract][Full Text] [Related]
14. KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors.
Sihto H; Sarlomo-Rikala M; Tynninen O; Tanner M; Andersson LC; Franssila K; Nupponen NN; Joensuu H
J Clin Oncol; 2005 Jan; 23(1):49-57. PubMed ID: 15545668
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
